(Q42632621)

4 November 2017

title

Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84. (English)

1 reference

4 November 2017

1 reference

Atkin SL

3

0 references

author name string

Weaver JU

series ordinal

1

1 reference

4 November 2017

Robertson D

series ordinal

2

1 reference

4 November 2017

publication date

1 September 2004

1 reference

Diabetes, Obesity and Metabolism

4 November 2017

published in

1 reference

4 November 2017

volume

6

1 reference

4 November 2017

issue

5

1 reference

4 November 2017

page(s)

344-352

1 reference

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00353.X

Effective diabetes care: a need for realistic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00353.X

Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00353.X

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00353.X

Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-8902.2004.00353.X

10.1111/J.1462-8902.2004.00353.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference